TUE guidance documents including new regulations on glucocorticoids In order to assist physicians and athletes, in the last few weeks, WADA published the following guidance documents on managing TUEs to include the new regulations on glucocorticoids: General document on glucocorticoids and TUEs Checklists for athletes and treating physicians on a number of medical conditions for which glucocorticoids may be used TUE Physician Guidelines for TUE Committees on how to evaluate TUE requests for glucocorticoids for different medical conditions Educational resources In addition to the guidance documents listed above, WADA has provided a number of educational resources as part of its Code Implementation Support Program (CISP), which can be accessed on the Agencys Anti-Doping Education and Learning Platform (ADEL)
The Retatrutide and GHK-Cu stack has been gaining traction among Canadian peptide researchers who are running serious fat-loss protocols and want to account for what happens to the body on the other side of that process
Pellets were resuspended in 100 mM triethylammonium bicarbonate buffer, digested with trypsin (37 C, overnight), then lyophilized
XENical in the prevention of diabetes in obese subjects (XENDOS) study a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients
TB-500: Actin Regulation and Cell Migration The mechanism of action of TB-500 is simpler and more upstream
